Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity. - Wikidata - awgldk - TriplyDB

Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.

Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.

http://www.wikidata.org/entity/Q34629133

about

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza Infection Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head Protective immunity and safety of a genetically modified influenza virus vaccine Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins.Alveolar Macrophages Prevent Lethal Influenza Pneumonia By Inhibiting Infection Of Type-1 Alveolar Epithelial Cells Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans New vaccines against influenza virus.IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection Asthma increases susceptibility to heterologous but not homologous secondary influenza Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.Diverse heterologous primary infections radically alter immunodominance hierarchies and clinical outcomes following H7N9 influenza challenge in mice Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.Novel universal influenza virus vaccine approaches Preexisting Antibody-Dependent Cellular Cytotoxicity-Activating Antibody Responses Are Stable Longitudinally and Cross-reactive Responses Are Not Boosted by Recent Influenza Exposure.Cross-immunity Against Avian Influenza A(H7N9) Virus in the Healthy Population Is Affected by Antigenicity-Dependent Substitutions.Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.Mucosal immunization with integrase-defective lentiviral vectors protects against influenza virus challenge in mice Development of an Alternative Modified Live Influenza B Virus Vaccine.Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines Pathogen evolution and the immunological niche.Fast vaccine design and development based on correlates of protection (COPs).Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection.CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection New Orf virus (Parapoxvirus) recombinant expressing H5 hemagglutinin protects mice against H5N1 and H1N1 influenza A virus.Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cells Coinfection. Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation The Immune Adaptor ADAP Regulates Reciprocal TGF-β1-Integrin Crosstalk to Protect from Influenza Virus Infection.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages.Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.Identification of positive selection in genes is greatly improved by using experimentally informed site-specific models.The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants.Progress on adenovirus-vectored universal influenza vaccines.Immunological considerations for developing antibody therapeutics for Influenza A.The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection.Cell-Mediated Immunity Against Antigenically Drifted Influenza A(H3N2) Viruses in Children During a Vaccine Mismatch Season.

P2860

Q26744622-5862597D-D11B-4FB6-999C-A8727FB15D32 Q26767517-CDE2DABB-FD16-4BC6-9CC5-C7ADFDD13DCD Q26783897-310328F5-69B0-416A-9E09-6F92155A1E58 Q27324763-30CD9C23-15CB-48F7-9D4F-AA2B8598C221 Q30151352-024A8BBE-4E43-4B0E-BAC2-011A856CE458 Q30275003-B7EACBA1-9DD2-476F-820F-C0CC7097C3B5 Q30354893-E185560A-ABD6-4FC3-8450-69DBF9EE103A Q30357932-F00463A6-5C4F-45B6-B5C8-4400A3FC801C Q30361079-0F2CBC54-387F-47C5-A3B0-C12C6FF02053 Q30363298-70647F49-BD49-4BA5-BB1A-71A70A4A8F4A Q30363454-5C72A24C-161A-417E-91F8-8F80CBB079F6 Q30371622-833C1F88-CE30-4C38-A721-6091D6B04464 Q30373077-075B3156-3BBA-43B8-AFB8-E277036D6EFC Q30375348-03A3A785-8326-467F-B632-D4AEAD6AE32F Q30380290-B5F86702-AF71-460C-96B7-CF034195401B Q30382787-D99BABAC-A8A9-4B38-A58D-7B1CCFE79EF2 Q30385071-7E2F0A08-4017-475A-BEBB-6A79F8950569 Q30391515-F09E2395-4C3C-479D-B067-DBCBC21C507F Q30394072-B82738CB-9401-45B3-A2DB-52C905B40772 Q30395259-E9D99DA3-5725-4C9B-89E8-5D542B388685 Q33604567-DD490B5F-243F-424F-AB67-6DFDA064064B Q33733453-D9DEAF22-00E7-445E-9776-84648259481D Q34057711-EE0EE53E-6E91-4BF2-B966-A5B4CB55B757 Q34078369-4259B4B4-26F9-45C0-9D2E-6DA6AD86EB01 Q34291098-246C0A90-FF52-450B-9BB1-FCBF20B7EB81 Q35070880-53236740-099D-40F2-971B-BD620D015BBE Q35073840-EDA8DB8F-752A-4697-B623-8407A120DF07 Q35078213-5C3537DD-C356-4778-BFAC-01DD2DC193A2 Q35110853-24EC4940-8512-4D3F-8F60-F1B70158A9B5 Q35216939-A4AE3C27-C1D3-4B88-A7FF-56630775A82B Q35613552-AA39DB46-1989-489D-9F7A-E18497DABACC Q35826733-121297FA-1661-4BB0-9073-9E6FAE5689A3 Q36281812-193CF5FB-38B7-4771-A94D-6A48CFBF3783 Q37336804-5AA55AB8-D562-4CE2-BC4D-EFFA71337486 Q37589347-1F6A8997-B20B-4A47-9978-EFE7DAAC553A Q37738010-7D8CCB3F-0C1A-4363-9F97-03555DB8399E Q38421971-4C2D2AEB-BD34-4058-8F1E-8A2B85F0C382 Q39184046-FCC9946F-2D4F-4748-ACBD-CE94336C85E2 Q40191149-3F93656B-69F0-4280-ACFB-285E6D1BDDD2 Q40618185-80990499-3A89-441D-8B1E-B50C249FD873

P2860

Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.

http://www.wikidata.org/entity/Q34629133

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Cooperativity between CD8+ T c ...... ypic influenza virus immunity.

@ast

Cooperativity between CD8+ T c ...... ypic influenza virus immunity.

@en

Cooperativity between CD8+ T c ...... ypic influenza virus immunity.

@nl

type

label

Cooperativity between CD8+ T c ...... ypic influenza virus immunity.

@ast

Cooperativity between CD8+ T c ...... ypic influenza virus immunity.

@en

Cooperativity between CD8+ T c ...... ypic influenza virus immunity.

@nl

prefLabel

Cooperativity between CD8+ T c ...... ypic influenza virus immunity.

@ast

Cooperativity between CD8+ T c ...... ypic influenza virus immunity.

@en

Cooperativity between CD8+ T c ...... ypic influenza virus immunity.

@nl

P1433

Q34629133-1BF3C8F6-07AE-4146-816A-266531BEE066

P1476

Q34629133-9511462F-6038-4DE4-9FCA-CD1CD80EAD37

P2093

Q34629133-09DED032-61C0-450F-8BE8-910D1DCFA6E9

Q34629133-18C99130-3130-4E09-A561-227E60BF350B

Q34629133-238588E8-DE77-45BA-8DFB-84F68ABDABA9

Q34629133-341AC628-699D-40D8-A5B8-66A3F1A94BE0

Q34629133-4FABD45D-5FC9-424A-8268-7661C11A3C8A

Q34629133-6B2C54CE-7DB2-457C-9C01-17E366041C94

Q34629133-8301CB3D-001A-4304-81F1-299186C3F007

Q34629133-8738D42E-68D1-414A-8BF6-33C9C55393DD

Q34629133-B0314750-A832-493E-83CC-3B41D90A2E6C

Q34629133-C4D5CD6D-4CC8-4BB7-938C-D8D36E4E34D7

P2860

Q34629133-003EF481-38F3-4A14-B97F-6D9603A50ECB

Q34629133-018FC827-AAAD-4201-868F-CB3A3486FDF0

Q34629133-01983A78-8F84-4118-912D-392781239F22

Q34629133-0A120F47-5663-4F2E-9D04-B70EFECE07B1

Q34629133-0A9B0B84-A78A-49CB-B36E-5480581D5286

Q34629133-0D5EBAD1-0F5A-4E52-926E-FAAD1F01AA14

Q34629133-1349A49B-923D-47D6-A058-C0CD325303E0

Q34629133-1396F0EC-1B5D-4B24-BD55-7C511E054D37

Q34629133-14C01E07-828D-4358-A4BF-9F3F5391E8A5

Q34629133-164ECD12-AA76-49D9-B6C1-FED6F569885C

P304

Q34629133-0D2F457D-A6F1-4D17-ACF7-2AF7680CD7E5

P31

Q34629133-8846D545-5BC2-4C81-99B6-EF98F20B83A7

P356

Q34629133-C021B61A-6B0E-4F3D-9597-80FAFC49BB29

P433

Q34629133-029B3C10-3BC3-4DBA-9A7C-B916CA7CAEAE

P478

Q34629133-F80ADC0D-BF01-46F7-9A42-145D74C52F09

P577

Q34629133-A3633816-8933-4E44-A9EE-F1308AE9FB28

P5875

Q34629133-D29A6198-6607-42BB-A667-7A8FEC827618

P698

Q34629133-C91B3EC8-4F45-4BAF-A1DF-3051AE085BD0

P921

Q34629133-65A6D032-CDDC-40A8-BA5B-9AA0F5E0D232

P932

Q34629133-C392A579-E339-4536-B81B-C62B468725A1

P356

JOURNAL.PPAT.1003207

P1433

P1476

Cooperativity between CD8+ T c ...... ypic influenza virus immunity.

@en

P2093

Amaya I Wolf

http://www.w3.org/2001/XMLSchema#string

Brian J Laidlaw

http://www.w3.org/2001/XMLSchema#string

David Artis

http://www.w3.org/2001/XMLSchema#string

E John Wherry

http://www.w3.org/2001/XMLSchema#string

Jan Erikson

http://www.w3.org/2001/XMLSchema#string

Jill M Angelosanto

http://www.w3.org/2001/XMLSchema#string

Krystyna Mozdzanowska

http://www.w3.org/2001/XMLSchema#string

Laurel A Monticelli

http://www.w3.org/2001/XMLSchema#string

Michael C Abt

http://www.w3.org/2001/XMLSchema#string

Mohammed-Alkhatim A Ali

http://www.w3.org/2001/XMLSchema#string

P2860

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity

Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses

Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution

Mortality associated with influenza and respiratory syncytial virus in the United States

Seasonal and pandemic influenza preparedness: science and countermeasures.

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response.

P304

e1003207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1003207

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236068420

http://www.w3.org/2001/XMLSchema#string

P698

23516357

http://www.w3.org/2001/XMLSchema#string

P921

P932

3597515

http://www.w3.org/2001/XMLSchema#string